Related Experiment Video
Updated: Nov 17, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
Pablo Castro-Córdova1,2, Paola Mora-Uribe1, Rodrigo Reyes-Ramírez1,2
1Microbiota-Host Interactions and Clostridia Research Group, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.
Abstract:
Clostridioides difficile spores produced during infection are important for the recurrence of the disease. Here, we show that C. difficile spores gain entry into the intestinal mucosa via pathways dependent on host fibronectin-α5β1 and vitronectin-αvβ1. The exosporium protein BclA3, on the spore surface, is required for both entry pathways. Deletion of the bclA3 gene in C. difficile, or pharmacological inhibition of endocytosis using nystatin, leads to reduced entry into the intestinal mucosa and reduced recurrence of the disease in a mouse model. Our findings indicate that C. difficile spore entry into the intestinal barrier can contribute to spore persistence and infection recurrence, and suggest potential avenues for new therapies.
Insights
Clostridioides difficile spores enter the intestinal lining using host proteins and the BclA3 spore protein. Blocking this entry reduces C. difficile recurrence in mice, suggesting new therapeutic targets.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Clostridioides difficile infection (CDI) recurrence is a significant clinical challenge.
- C. difficile spores are crucial for disease persistence and transmission.
- Understanding spore-host interactions is key to preventing CDI recurrence.
Purpose of the Study:
- To elucidate the mechanisms of C. difficile spore entry into the intestinal mucosa.
- To identify host factors and bacterial components involved in spore invasion.
- To evaluate therapeutic strategies targeting spore entry to reduce CDI recurrence.
Main Methods:
- Investigated C. difficile spore interaction with intestinal epithelial cells.
- Utilized cell-based assays and a mouse model of CDI.
- Employed genetic deletion of the C. difficile bclA3 gene.
- Assessed the effect of pharmacological inhibition of endocytosis (nystatin).
Main Results:
- C. difficile spores utilize host fibronectin-α5β1 and vitronectin-αvβ1 pathways for intestinal entry.
- The exosporium protein BclA3 is essential for spore adherence and invasion via these pathways.
- Deletion of bclA3 or inhibition of endocytosis significantly reduced spore entry into the mucosa.
- Reduced mucosal entry correlated with decreased C. difficile recurrence in a mouse model.
Conclusions:
- C. difficile spore entry into the intestinal mucosa is a critical step for infection persistence and recurrence.
- Host fibronectin and vitronectin receptors, along with the bacterial BclA3 protein, mediate this entry.
- Targeting C. difficile spore-host interactions presents a promising therapeutic strategy for preventing CDI recurrence.
Related Concept Videos
Renewal of Intestinal Stem Cells
Endospores and Sporulation
Fungal Phylum Microsporidia
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

